Dr. Stephanie Cape, Head of Research and Development, Scientific Affairs
Dr. Stephanie Cape heads the Research and Development team within Scientific Affairs at Labcorp Drug Development. The Scientific Affairs team is focused on ensuring that Labcorp Drug Development is positioned with the right technologies and expertise to effectively support the rapidly evolving needs of the pharmaceutical testing industry. In this role, Stephanie focuses on advancing laboratory technologies to enable new capabilities spanning characterization, clinical chemistry and bioanalysis.
Over the past 10 years with Labcorp Drug Development, Stephanie has served in a variety of scientific leadership roles, been actively engaged in a number of industry groups and grown a particular interest in enabling new technologies. She is currently serving as the co-chair of the American Association of Pharmaceutical Scientists (AAPS) Bioanalytical Community, the chair for the Land O’ Lakes Bioanalytical Conference, the chair for the AAPS Mass Spectrometry Focus Group, a subject matter expert for the Bioanalysis Zone and member of the Bioanalysis journal editorial board. Stephanie is also highly engaged in the global Patient Centric Sampling Interest Group and AAPS Microsampling and Patient Centric Sampling team.
Stephanie has authored more than 30 peer-reviewed publications, including four book chapters, and has contributed to many posters and presentations.
She received her BS in chemistry from the University of Illinois Urbana-Champaign in 2003 and her PhD in analytical chemistry from the University of Wisconsin-Madison in 2007.